| Term 
 | Definition 
 
        | dopaminergic drug dopamine receptor agonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | dopaminergic drug dopamine receptor agonist
 alpha 2 agonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | dopaminergic drug dopamine receptor agonist
 alpha 1/2 agonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | levodopa-carbidopa-entacapone |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | dopaminergic drug dopamine receptor agonist
 alpha 2 partial agonist receptor
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | dopaminergic drug dopamine receptor agonist
 alpha 2 agonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | dopaminergic drug dopamine receptor agonist
 alpha 2 antagonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | anticholinergic drug muscarinic antagonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | anticholingergic drug muscarinic antagonist
 neuronal acetylcholine receptor alpha antagonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | anticholinergic drug muscarinic antagonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | drug for alzheimer's disease |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | drug for alzheimer's disease |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | alzheimer's disease alpha 7 nicotinic cholinergic receptor antagonist
 dopamine receptor agonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Immune attacks in MS blocks potassium channel blocker
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Immune attacks in MS interferon alpha/beta receptor 1/2 agonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Immune attacks in MS interferon alpha/beta receptor 1/2 agonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Relief of MS symptoms partial alpha 1 agonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Relief of MS symptoms domapine agonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | antispasmodic drug muscarinic antagonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antispasmodic drug alpha 2 agonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antispasmodic drug ryanodine receptor 1 antagonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | nondepolarizing neuromuscular blocking drug 
 neuronal acetylcholine receptor subunit alpha-2
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nondepolarizing neuromuscular blocking drug 
 neuronal acetylcholine receptor subunit alpha-2
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nondepolarizing neuromuscular blocking drug 
 neuronal acetylcholine receptor subunit alpha-2 antagonist
 muscarinic atagonist, partial agonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nondepolarizing neuromuscular blocking drug 
 neuronal acetylcholine receptor subunit alpha-2 antagonist
 muscarinic antagonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nondepolarizing neuromuscular blocking drug 
 neuronal acetylcholine receptor subunit alpha-2 antagonist
 muscarinic antagonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nondepolarizing neuromuscular blocking drug 
 neuronal acetylcholine receptor subunit alpha-2 antagonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nondepolarizing neuromuscular blockiing drug 
 neuronal acetylcholine receptor subunit alpha-2 antagonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | depolarizing neuromuscular blocking drug alpha 7 nicotinic cholinergic agonist
 muscarinic agonist
 |  | 
        |  |